Since its establishment in 1998, Yuwell Medical, listed on the Shenzhen Stock Exchange (002223.SZ), has been a leading provider of healthcare products and service solutions in China. In 2024, the company generated over $1 billion in revenue and serves 10 medical fields, including respiratory therapy, diabetes management, infection control, AEDs, surgical devices, and traditional Chinese medicine, and others. With 9 state-of-the-art R&D centers, 7 advanced production facilities, and 4 international subsidiaries outside China, Yuwell’s global presence spans over 100 countries. The company supports more than 300,000 healthcare institutions and benefits 300 million households worldwide. As a global leader in home healthcare medical devices, Yuwell is dedicated to transforming lives worldwide through accessible, high-quality medical technology. Through continuous innovation and strategic partnerships, Yuwell is driving meaningful progress in worldwide health development, empowering people around the world to lead healthier, more fulfilling lives.